TipRanks
StemCell Institute (JP:7096)
:7096
Japanese Market
7096
StemCell Institute
RESEARCH TOOLSreports
Want to see JP:7096 full AI Analyst Report?

StemCell Institute (7096) Ratios

0 Followers

StemCell Institute Ratios

JP:7096's free cash flow for Q4 2025 was ¥0.58. For the 2025 fiscal year, JP:7096's free cash flow was decreased by ¥ and operating cash flow was ¥-0.02. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 1.17 1.17 1.20 1.20 1.32
Quick Ratio
 1.16 1.16 1.19 1.19 1.31
Cash Ratio
 0.61 0.63 0.74 0.76 0.97
Solvency Ratio
 0.06 0.06 0.11 0.11 0.09
Operating Cash Flow Ratio
 0.00 0.02 0.11 0.09 0.03
Short-Term Operating Cash Flow Coverage
 0.00 1.04 6.96 158.74 74.77
Net Current Asset Value
¥ 297.44M¥ 263.26M¥ 283.76M¥ 664.58M¥ 1.03B
Leverage Ratios
Debt-to-Assets Ratio
 0.07 0.06 0.07 <0.01 <0.01
Debt-to-Equity Ratio
 0.23 0.18 0.20 <0.01 <0.01
Debt-to-Capital Ratio
 0.19 0.15 0.16 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.12 0.12 0.14 0.00 0.00
Financial Leverage Ratio
 3.13 3.03 2.86 2.43 2.53
Debt Service Coverage Ratio
 1.00 3.84 7.53 191.49 241.24
Interest Coverage Ratio
 31.59 37.20 348.18 0.00 0.00
Debt to Market Cap
 0.08 0.06 0.04 <0.01 <0.01
Interest Debt Per Share
 63.77 47.46 50.79 1.05 0.67
Net Debt to EBITDA
 -6.38 -6.21 -3.86 -5.31 -8.24
Profitability Margins
Gross Profit Margin
60.14%60.90%63.16%63.51%63.88%
EBIT Margin
6.51%7.94%21.16%16.68%14.23%
EBITDA Margin
12.42%13.52%25.95%21.52%19.25%
Operating Profit Margin
6.30%7.21%15.62%16.68%14.23%
Pretax Profit Margin
6.83%7.75%21.12%17.79%13.34%
Net Profit Margin
5.18%5.55%14.40%12.53%9.47%
Continuous Operations Profit Margin
3.47%4.66%14.40%12.53%9.47%
Net Income Per EBT
75.84%71.59%68.20%70.46%70.99%
EBT Per EBIT
108.50%107.46%135.17%106.66%93.75%
Return on Assets (ROA)
1.72%1.92%5.13%4.75%3.41%
Return on Equity (ROE)
5.50%5.81%14.68%11.55%8.62%
Return on Capital Employed (ROCE)
4.71%5.64%13.08%14.87%12.50%
Return on Invested Capital (ROIC)
2.25%3.33%8.74%10.46%8.87%
Return on Tangible Assets
1.77%1.97%5.22%4.78%3.42%
Earnings Yield
2.00%2.02%2.78%1.61%0.77%
Efficiency Ratios
Receivables Turnover
 1.14 1.21 1.46 1.57 1.84
Payables Turnover
 35.23 32.35 39.60 25.65 25.03
Inventory Turnover
 18.76 20.35 19.36 21.42 19.20
Fixed Asset Turnover
 1.81 2.04 2.32 3.73 3.23
Asset Turnover
 0.33 0.35 0.36 0.38 0.36
Working Capital Turnover Ratio
 3.58 3.44 3.33 2.66 1.87
Cash Conversion Cycle
 328.06 309.37 259.82 235.82 202.87
Days of Sales Outstanding
 318.96 302.71 250.18 233.02 198.44
Days of Inventory Outstanding
 19.46 17.94 18.85 17.04 19.01
Days of Payables Outstanding
 10.36 11.28 9.22 14.23 14.58
Operating Cycle
 338.42 320.65 269.03 250.05 217.46
Cash Flow Ratios
Operating Cash Flow Per Share
 0.00 7.28 45.67 32.66 9.73
Free Cash Flow Per Share
 0.00 -33.25 -0.99 12.98 3.88
CapEx Per Share
 0.00 40.53 46.65 19.68 5.85
Free Cash Flow to Operating Cash Flow
 0.00 -4.57 -0.02 0.40 0.40
Dividend Paid and CapEx Coverage Ratio
 0.00 0.18 0.64 1.66 1.66
Capital Expenditure Coverage Ratio
 0.00 0.18 0.98 1.66 1.66
Operating Cash Flow Coverage Ratio
 0.00 0.16 0.90 31.03 14.47
Operating Cash Flow to Sales Ratio
 0.00 0.03 0.17 0.13 0.05
Free Cash Flow Yield
0.00%-4.34%-0.07%0.69%0.15%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 50.03 49.61 36.02 61.94 130.13
Price-to-Sales (P/S) Ratio
 2.59 2.75 5.19 7.76 12.32
Price-to-Book (P/B) Ratio
 2.70 2.88 5.29 7.15 11.21
Price-to-Free Cash Flow (P/FCF) Ratio
 0.00 -23.04 -1.37K 144.87 647.99
Price-to-Operating Cash Flow Ratio
 0.00 105.23 29.72 57.57 258.55
Price-to-Earnings Growth (PEG) Ratio
 -1.24 -0.84 1.47 1.10 2.80
Price-to-Fair Value
 2.70 2.88 5.29 7.15 11.21
Enterprise Value Multiple
 14.49 14.15 16.13 30.77 55.78
Enterprise Value
 5.10B 5.38B 11.22B 16.43B 22.45B
EV to EBITDA
 14.49 14.15 16.13 30.77 55.78
EV to Sales
 1.80 1.91 4.19 6.62 10.74
EV to Free Cash Flow
 0.00 -16.01 -1.11K 123.55 564.58
EV to Operating Cash Flow
 0.00 73.12 23.98 49.10 225.27
Tangible Book Value Per Share
 304.65 282.10 243.66 258.72 221.93
Shareholders’ Equity Per Share
 270.03 265.58 256.59 262.78 224.33
Tax and Other Ratios
Effective Tax Rate
 0.49 0.40 0.32 0.30 0.29
Revenue Per Share
 281.26 278.38 261.60 242.15 204.10
Net Income Per Share
 14.57 15.44 37.67 30.35 19.33
Tax Burden
 0.76 0.72 0.68 0.70 0.71
Interest Burden
 1.05 0.98 1.00 1.07 0.94
Research & Development to Revenue
 0.00 0.00 <0.01 <0.01 <0.01
SG&A to Revenue
 0.54 0.54 0.48 0.38 0.40
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.00 0.47 1.21 1.08 0.50
Currency in JPY